Literature DB >> 25747750

Cathepsins in heart disease-chewing on the heartache?

Jordan Blondelle1, Stephan Lange1, Barry H Greenberg1, Randy T Cowling2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25747750      PMCID： PMC4578146          DOI： 10.1152/ajpheart.00125.2015

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN： 0363-6135            Impact factor:   4.733


× No keyword cloud information.
  34 in total

Review 1.  Molecular mechanism of NLRP3 inflammasome activation.

Authors:  Chengcheng Jin; Richard A Flavell
Journal:  J Clin Immunol       Date:  2010-06-30       Impact factor: 8.317

Review 2.  Cathepsin B as a cancer target.

Authors:  Christopher S Gondi; Jasti S Rao
Journal:  Expert Opin Ther Targets       Date:  2013-01-08       Impact factor: 6.902

Review 3.  Cathepsin K inhibitors: a novel target but promising approach in the treatment of osteoporosis.

Authors:  Asadul Mazid Helali; Farhana Matin Iti; Isa Naina Mohamed
Journal:  Curr Drug Targets       Date:  2013-12       Impact factor: 3.465

4.  Plasma cathepsin D isoforms and their active metabolites increase after myocardial infarction and contribute to plasma renin activity.

Authors:  R Haris Naseem; Wade Hedegard; Timothy D Henry; Jennifer Lessard; Kathryn Sutter; Stephen A Katz
Journal:  Basic Res Cardiol       Date:  2004-11-10       Impact factor: 17.165

Review 5.  Autophagic cell death and its execution by lysosomal cathepsins.

Authors:  Y Uchiyama
Journal:  Arch Histol Cytol       Date:  2001-08

Review 6.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

Review 7.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Authors:  J N Cohn; R Ferrari; N Sharpe
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

8.  Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality.

Authors:  Krisztina Zsebo; Alex Yaroshinsky; Jeffrey J Rudy; Kim Wagner; Barry Greenberg; Mariell Jessup; Roger J Hajjar
Journal:  Circ Res       Date:  2013-09-24       Impact factor: 17.367

Review 9.  Cathepsins mediate tumor metastasis.

Authors:  Gong-Jun Tan; Zheng-Ke Peng; Jin-Ping Lu; Fa-Qing Tang
Journal:  World J Biol Chem       Date:  2013-11-26

Review 10.  Cysteine cathepsins: from structure, function and regulation to new frontiers.

Authors:  Vito Turk; Veronika Stoka; Olga Vasiljeva; Miha Renko; Tao Sun; Boris Turk; Dušan Turk
Journal:  Biochim Biophys Acta       Date:  2011-10-12
View more
  3 in total

1.  Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway.

Authors:  Tianming Qiu; Pei Pei; Xiaofeng Yao; Liping Jiang; Sen Wei; Zhidong Wang; Jie Bai; Guang Yang; Ni Gao; Lei Yang; Shuangyue Qi; Rushan Yan; Xiaofang Liu; Xiance Sun
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

Review 2.  Lysosomal Abnormalities in Cardiovascular Disease.

Authors:  Congwu Chi; Andrew S Riching; Kunhua Song
Journal:  Int J Mol Sci       Date:  2020-01-27       Impact factor: 5.923

3.  Inappropriate cathepsin K secretion promotes its enzymatic activation driving heart and valve malformation.

Authors:  Po-Nien Lu; Trevor Moreland; Courtney J Christian; Troy C Lund; Richard A Steet; Heather Flanagan-Steet
Journal:  JCI Insight       Date:  2020-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.